| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Immunology, Imperial College School of Medicine, St. Mary’s, London, United Kingdom;
Oxford Transplant Centre, Nuffield Department of Surgery, Churchill Hospital, Oxford, United Kingdom;
Princeton Institute for Advanced Study, Princeton, NJ 08540;
§
Division of Molecular Pathology, Centre for Chronic Viral Diseases,
¶
Department of Medical Informatics, and
||
Third Department of Internal Medicine, Faculty of Medicine, Kagoshima University, Kagoshima, Japan
The inflammatory disease human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy (HAM/TSP) occurs in only 1–2% of HTLV-I-infected individuals and is associated with a high provirus load of HTLV-I. We hypothesize that a person’s risk of developing HAM/TSP depends upon the efficiency of their immune response to the virus, which differs between individuals because of polymorphism in genes that influence this response. Previously we showed that the possession of HLA-A*02 was associated with a lower risk of HAM/TSP, and with a lower provirus load in healthy carriers of HTLV-I. However, HLA-A*02 did not account for all the observed difference in the risk of HAM/TSP. Here we present evidence, in the same study population in Japan, that HLA-Cw*08 was also associated with disease protection (probability value, two-tailed test = 0.002) and with a lower proviral load in healthy carriers. Possession of the A*02 and/or Cw*08 genes prevented 36% of potential HAM/TSP cases. In contrast, HLA-B*5401 was associated with a higher susceptibility to HAM/TSP (probability value, two-tailed test = 0.0003) and with a higher provirus load in HAM/TSP patients. At a given provirus load, B*5401 appeared to increase the risk of disease. The fraction of HAM/TSP cases attributable to B*5401 was 17%. Furthermore, individuals who were heterozygous at all three HLA class I loci have a lower HTLV-I provirus load than those who were homozygous at one or more loci. These results are consistent with the proposal that a strong class I-restricted CTL response to HTLV-I reduces the proviral load and hence the risk of disease.
This article has been cited by other articles:
|
|
 |
|
  F. Toulza, A. Heaps, Y. Tanaka, G. P. Taylor, and C. R. M. Bangham High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response Blood, May 15, 2008; 111(10): 5047 - 5053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Stoffels and H. G. Spencer An Asymmetric Model of Heterozygote Advantage at Major Histocompatibility Complex Genes: Degenerate Pathogen Recognition and Intersection Advantage Genetics, March 1, 2008; 178(3): 1473 - 1489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ilmonen, D. J. Penn, K. Damjanovich, L. Morrison, L. Ghotbi, and W. K. Potts Major Histocompatibility Complex Heterozygosity Reduces Fitness in Experimentally Infected Mice Genetics, August 1, 2007; 176(4): 2501 - 2508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Asquith, Y. Zhang, A. J. Mosley, C. M. de Lara, D. L. Wallace, A. Worth, L. Kaftantzi, K. Meekings, G. E. Griffin, Y. Tanaka, et al. In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection PNAS, May 8, 2007; 104(19): 8035 - 8040. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-M. A. Chen, S.-Y. Liang, Y.-P. Shih, C.-Y. Chen, Y.-M. Lee, L. Chang, S.-Y. Jung, M.-S. Ho, K.-Y. Liang, H.-Y. Chen, et al. Epidemiological and Genetic Correlates of Severe Acute Respiratory Syndrome Coronavirus Infection in the Hospital with the Highest Nosocomial Infection Rate in Taiwan in 2003 J. Clin. Microbiol., February 1, 2006; 44(2): 359 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Asquith, A. J. Mosley, A. Barfield, S. E. F. Marshall, A. Heaps, P. Goon, E. Hanon, Y. Tanaka, G. P. Taylor, and C. R. M. Bangham A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load J. Gen. Virol., May 1, 2005; 86(5): 1515 - 1523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Sabouri, M. Saito, K. Usuku, S. N. Bajestan, M. Mahmoudi, M. Forughipour, Z. Sabouri, Z. Abbaspour, M. E. Goharjoo, E. Khayami, et al. Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals J. Gen. Virol., March 1, 2005; 86(3): 773 - 781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Vine, A. G. Heaps, L. Kaftantzi, A. Mosley, B. Asquith, A. Witkover, G. Thompson, M. Saito, P. K. C. Goon, L. Carr, et al. The Role of CTLs in Persistent Viral Infection: Cytolytic Gene Expression in CD8+ Lymphocytes Distinguishes between Individuals with a High or Low Proviral Load of Human T Cell Lymphotropic Virus Type 1 J. Immunol., October 15, 2004; 173(8): 5121 - 5129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Umehara, S. Nagatomo, K. Yoshishige, M. Saito, Y. Furukawa, K. Usuku, and M. Osame Chronic progressive cervical myelopathy with HTLV-I infection: Variant form of HAM/TSP? Neurology, October 12, 2004; 63(7): 1276 - 1280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. M. Bangham The immune control and cell-to-cell spread of human T-lymphotropic virus type 1 J. Gen. Virol., December 1, 2003; 84(12): 3177 - 3189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. C. Goon, T. Igakura, E. Hanon, A. J. Mosley, B. Asquith, K. G. Gould, G. P. Taylor, J. N. Weber, and C. R. M. Bangham High Circulating Frequencies of Tumor Necrosis Factor Alpha- and Interleukin-2-Secreting Human T-Lymphotropic Virus Type 1 (HTLV-1)-Specific CD4+ T Cells in Patients with HTLV-1-Associated Neurological Disease J. Virol., September 1, 2003; 77(17): 9716 - 9722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J J Z. Imirizaldu, J C G. Esteban, I R. Axpe, T P. Concha, F V. Juanes, I A. Susaeta, and J M C. Carranceja Post-transplantation HTLV-1 myelopathy in three recipients from a single donor J. Neurol. Neurosurg. Psychiatry, August 1, 2003; 74(8): 1080 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Penn, K. Damjanovich, and W. K. Potts MHC heterozygosity confers a selective advantage against multiple-strain infections PNAS, August 20, 2002; 99(17): 11260 - 11264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. M. Boon, G. de Mutsert, Y. M. F. Graus, R. A. M. Fouchier, K. Sintnicolaas, A. D. M. E. Osterhaus, and G. F. Rimmelzwaan The Magnitude and Specificity of Influenza A Virus-Specific Cytotoxic T-Lymphocyte Responses in Humans Is Related to HLA-A and -B Phenotype J. Virol., January 15, 2002; 76(2): 582 - 590. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
